Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFusion Antibodies Regulatory News (FAB)

Share Price Information for Fusion Antibodies (FAB)

Share Price is delayed by 15 minutes
Get Live Data
11.50    -0.50 (-4.17%)
Bid:
11.00
Ask:
12.00
Spread: 1.00 (9.091%)
Market Cap: £14.39m
FAB Live PriceLast checked at - London Stock Exchange

Intraday Fusion Antibodies Share Chart

Site Update

11 Nov 2008 07:00

RNS Number : 8653H
Fabian Romania Limited
11 November 2008
 

Fabian Romania Limited ("Fabian Romania" or the "Company")

Fabian Romania achieves Building Permit for "The Orchard" residential development site in Timisoara.

Fabian Romania along with its development partner Coltex Construct has been granted the building permit for its residential development scheme of 429 apartments in Timisoara.

The Orchard will provide 429 high quality apartments constructed in two phases, totalling 38,812 sqm with an additional 540 car spaces. 

Designed by international architects, Jestico Whiles, the Directors of Fabian Romania believe that it will provide a new degree of quality residential product not seen before in the local market. The site is located 10 minutes to the north west of Timisoara city centre in a residential neighbourhood with good access just off Strada Textilistolor, one of the main routes travelling north out of the city. 

Timisoara is built on the site of an historical Roman fortress. Over the years it has been influenced by many cultures and is now an important university city with strong links to its industrial heritage. The population has expanded rapidly over the last 10 years to over 300,000. International companies have invested in the city including Continental, Nestle and Procter & Gamble. As the wealth of the city has grown this has created demand for residential development.

Commenting on the transaction, Mark Owen, Property Director of Fabian Capital, the Company's Investment Manager said: 

"This has been a phased land acquisition and we are pleased to have achieved all the permits necessary to start construction. The scheme is an excellent design and well located just north of the city and close to existing retail shopping malls. In light of current market conditions we have secured the value of the site by obtaining these permits and will assess market conditions early next year and establish when the time is right for construction to commence."

Enquiries

 

Fabian Capital:

Anthony Foster +44 20 7499 9988

 

Deloitte Corporate Finance - Nominated Adviser to Fabian Romania

 

Mike Bell +44 20 7007 1463

 

Shore Capital Stockbrokers Limited - Joint Broker to Fabian Romania

 

Dru Danford +44 20 7408 2090

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCEAXFEFLFPFFE
Date   Source Headline
8th Jun 202310:39 amRNSResult of GM and total voting rights
31st May 20235:00 pmRNSTotal Voting Rights
26th May 20234:57 pmRNSHolding(s) in Company
26th May 20231:33 pmRNSHolding(s) in Company
23rd May 20237:00 amRNSResult of Retail Offer and Notice of GM
19th May 202310:01 amRNSREX Retail Offer
19th May 202310:00 amRNSPlacing, Subscription and Retail Offer
3rd Apr 20237:00 amRNSBlock listing Interim Review
31st Mar 20237:00 amRNSChange of Registered Office
21st Mar 20237:00 amRNSPatent application
6th Mar 202311:05 amRNSSecond Price Monitoring Extn
6th Mar 202311:00 amRNSPrice Monitoring Extension
6th Mar 20237:00 amRNSTrading Statement
9th Feb 20237:00 amRNSR&D update: Mammalian Display service
9th Jan 20234:40 pmRNSSecond Price Monitoring Extn
9th Jan 20234:35 pmRNSPrice Monitoring Extension
9th Jan 20232:05 pmRNSSecond Price Monitoring Extn
9th Jan 20232:00 pmRNSPrice Monitoring Extension
9th Jan 202311:05 amRNSSecond Price Monitoring Extn
9th Jan 202311:00 amRNSPrice Monitoring Extension
5th Dec 20227:00 amRNSHalf-year Report
24th Nov 20227:00 amRNSNotice of Results
31st Oct 20221:47 pmRNSDirector/PDMR Shareholding
3rd Oct 20227:00 amRNSBlock admission six monthly return
23rd Sep 202211:44 amRNSResult of AGM
20th Sep 20221:36 pmRNSDirector/PDMR Shareholding
15th Sep 20223:41 pmRNSGrant of options
14th Sep 20222:05 pmRNSSecond Price Monitoring Extn
14th Sep 20222:01 pmRNSPrice Monitoring Extension
6th Sep 20227:00 amRNSGrant of options
1st Sep 20227:00 amRNSNotice of AGM and Director change
23rd Aug 20227:00 amRNSFinal Results
9th Aug 20227:00 amRNSBispecific designs patent application
5th Aug 20224:41 pmRNSSecond Price Monitoring Extn
5th Aug 20224:35 pmRNSPrice Monitoring Extension
28th Jul 20227:00 amRNSAppointment of Chief Executive Officer
6th May 20227:00 amRNSTrading update
1st Apr 20227:00 amRNSBlock admission six monthly return
14th Mar 20227:00 amRNSUpdate on Board changes
28th Feb 20227:00 amRNSDirector changes
22nd Feb 20224:41 pmRNSSecond Price Monitoring Extn
22nd Feb 20224:35 pmRNSPrice Monitoring Extension
21st Feb 20227:00 amRNSDirectorate Change
10th Feb 202212:49 pmRNSStmnt re Share Price Movement
14th Jan 20227:00 amRNSFormation of New Scientific Advisory Panel
11th Jan 20221:26 pmRNSHolding(s) in Company
31st Dec 20217:00 amRNSTotal Voting Rights
16th Dec 20217:00 amRNSExercise of share options and total voting rights
14th Dec 20217:00 amRNSExercise of share options and total voting rights
6th Dec 20217:00 amRNSHalf-year Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.